BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Araki N, Tsuruoka S, Hasegawa G, Yanagihara H, Omasa T, Enosawa S, Yamazoe Y, Fujimura A. Inhibition of CYP3A4 by 6',7'-dihydroxybergamottin in human CYP3A4 over-expressed hepG2 cells. J Pharm Pharmacol 2012;64:1715-21. [PMID: 23146034 DOI: 10.1111/j.2042-7158.2012.01562.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Stohs SJ, Miller H, Romano F. Absence of furanocoumarins in Advantra Z® (Citrus aurantium, bitter orange) extracts. J Diet Suppl 2014;11:288-93. [PMID: 25026202 DOI: 10.3109/19390211.2014.937047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Hadi NSA, Bankoglu EE, Schott L, Leopoldsberger E, Ramge V, Kelber O, Sievers H, Stopper H. Genotoxicity of selected pyrrolizidine alkaloids in human hepatoma cell lines HepG2 and Huh6. Mutat Res 2021;861-862:503305. [PMID: 33551105 DOI: 10.1016/j.mrgentox.2020.503305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
3 Michaels S, Wang MZ. The revised human liver cytochrome P450 "Pie": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics. Drug Metab Dispos 2014;42:1241-51. [PMID: 24816681 DOI: 10.1124/dmd.114.058040] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]